Home > Income Statement > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Appropriations

    Back to Income Statement
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best 1M Momentum Mid Cap Stocks
AD     Remove this Ad

GLENMARK PHARMACEUTICALS Last 5 Year Appropriations History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Appropriations ₹7,955 Cr₹9,508 Cr₹8,175 Cr₹7,300 Cr₹6,391 Cr

What is the latest Appropriations of GLENMARK PHARMACEUTICALS ?

The latest Appropriations ratio of GLENMARK PHARMACEUTICALS is ₹7,955 Cr based on Mar2025 Consolidated results.
Year Appropriations
Mar2025₹7,955 Cr
Mar2024₹9,508 Cr
Mar2023₹8,175 Cr
Mar2022₹7,300 Cr
Mar2021₹6,391 Cr

How is Appropriations of GLENMARK PHARMACEUTICALS Trending?

Years Appropriations % Change
Mar2025 ₹7,955 Cr
-16.33
Mar2024 ₹9,508 Cr
16.30
Mar2023 ₹8,175 Cr
12.00
Mar2022 ₹7,300 Cr
14.22
Mar2021 ₹6,391 Cr -

Compare Appropriations of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹60,325.9 Cr 4.9% 6% 63.6% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,028.0 Cr 0.3% 9% 8.6% Stock Analytics
DIVIS LABORATORIES ₹170,237.0 Cr 1.9% 5.9% 12.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,801.0 Cr 0.6% 9.5% 45% Stock Analytics
CIPLA ₹108,861.0 Cr 1.6% 1.8% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,435.0 Cr -1.5% 5.7% 14.5% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

4.9%

6%

63.6%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses